Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: Neurotensin evidence and protocol review
Also known as: NT peptide
Neurotensin is a 13-amino-acid neuropeptide with roles in modulating dopaminergic neurotransmission, analgesia, thermoregulation, and gastrointestinal secretion. It has been documented immunohistochemically as co-expressed with VIP within some individual tumor cells (notably in VIPoma syndrome research), and is studied more broadly as part of a family of neuropeptides (alongside substance P, VIP, and neuropeptide Y) acting on myeloid immune cells.
Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.
Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Amounts and schedules are separated by administration route. Evidence badges distinguish labels, human studies, preclinical work, community reports, and evidence gaps.
Human experimental dosing is study- and analog-specific; no consumer protocol exists
Context: neurotensin pharmacology literature
Formulation: Route-specific sterile formulation and professional handling requirements apply; concentration cannot be inferred from an oral or topical product.
Route safety: Non-human or laboratory exposure. It cannot be converted into a human dose.
Human experimental dosing is study- and analog-specific; no consumer protocol exists
Context: neurotensin pharmacology literature
Route safety: Non-human or laboratory exposure. It cannot be converted into a human dose.
No route-specific amount established in the reviewed record.
Context: The catalog identifies this route, but its reviewed sources do not establish a separate amount and schedule for it.
Formulation: Route-specific sterile formulation and professional handling requirements apply; concentration cannot be inferred from an oral or topical product.
Route safety: No route-specific protocol is established. Do not infer an amount from another route, component, or formulation.
2.3 pmol/kg/min
Context: Pharmacokinetic and hormone-response study in five healthy human participants
Formulation: Synthetic neurotensin research infusion
Route safety: Human research exposure only, not an approved therapeutic regimen. Do not convert the infusion rate to a bolus or another route.
Do not convert an amount between routes. Bioavailability, formulation, sterility, monitoring, and clinical context differ by route. Research-use context only; independently verify every cited source.
Native neurotensin is rapidly degraded; analog data cannot be imported without exact identity.
Supplementary research context only. Not medical advice or a treatment recommendation.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Published articles on this site that mention Neurotensin or one of its catalog aliases.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.